Jackson Creek Investment Advisors LLC Makes New Investment in Phibro Animal Health Corporation (NASDAQ:PAHC)

Jackson Creek Investment Advisors LLC bought a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 66,075 shares of the company's stock, valued at approximately $1,411,000. Jackson Creek Investment Advisors LLC owned 0.16% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of PAHC. Charles Schwab Investment Management Inc. increased its holdings in shares of Phibro Animal Health by 8.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company's stock worth $6,104,000 after acquiring an additional 22,263 shares during the period. Raymond James Financial Inc. bought a new position in Phibro Animal Health in the 4th quarter valued at about $1,103,000. Amundi grew its position in Phibro Animal Health by 185.5% in the 4th quarter. Amundi now owns 9,855 shares of the company's stock valued at $212,000 after buying an additional 6,403 shares in the last quarter. Semanteon Capital Management LP bought a new position in Phibro Animal Health in the 4th quarter valued at about $417,000. Finally, Summit Global Investments bought a new position in Phibro Animal Health in the 4th quarter valued at about $571,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on PAHC shares. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research report on Monday, June 16th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the company an "equal weight" rating in a research report on Wednesday, June 25th. Finally, JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $24.40.

Phibro Animal Health Trading Up 0.5%

Shares of PAHC traded up $0.15 during midday trading on Friday, hitting $29.88. The stock had a trading volume of 11,523 shares, compared to its average volume of 222,719. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $31.80. The business has a 50-day simple moving average of $25.48 and a two-hundred day simple moving average of $22.64. The firm has a market cap of $1.21 billion, a P/E ratio of 38.60, a price-to-earnings-growth ratio of 0.51 and a beta of 0.75. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. As a group, equities analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.61%. The ex-dividend date of this dividend was Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.